Minimally invasive third ventriculostomy with stereotactic internal shunt placement for the treatment of tumor-associated noncommunicating hydrocephalus.
Minimally invasive
Obstructive hydrocephalus
Stereotactic ventriculostomy
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
07 Sep 2023
07 Sep 2023
Historique:
received:
24
04
2023
accepted:
11
08
2023
medline:
7
9
2023
pubmed:
7
9
2023
entrez:
7
9
2023
Statut:
aheadofprint
Résumé
Intracranial tumors can cause obstructive hydrocephalus (OH). Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV). In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy. In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated. Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5-88) were analyzed. OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases). Following sTVIP, 74.2% of patients experienced symptomatic improvement. Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.25; 95% CI 4.1-521.1; p = 0.0036). Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.3%). One patient required local revision due to CSF fistula (2.6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption. However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3-32 months). No surgery-related mortality was observed. sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period. Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.
Sections du résumé
BACKGROUND
BACKGROUND
Intracranial tumors can cause obstructive hydrocephalus (OH). Most often, symptomatic treatment is pursued through ventriculoperitoneal shunt (VS) or endoscopic third ventriculostomy (ETV). In this study, we propose stereotactic third ventriculostomy with internal shunt placement (sTVIP) as an alternative treatment option and assess its safety and efficacy.
METHODS
METHODS
In this single-center, retrospective analysis, clinical symptoms, procedure-related complications, and revision-free survival of all patients with OH due to tumor formations treated by sTVIP between January 2010 and December 2021 were evaluated.
RESULTS
RESULTS
Clinical records of thirty-eight patients (11 female, 27 male) with a mean age of 40 years (range 5-88) were analyzed. OH was predominantly (in 92% of patients) caused by primary brain tumors (with exception of 3 cases with metastases). Following sTVIP, 74.2% of patients experienced symptomatic improvement. Preoperative headache was a significant predictor of postoperative symptomatic improvement (OR 26.25; 95% CI 4.1-521.1; p = 0.0036). Asymptomatic hemorrhage was detected along the stereotactic trajectory in 2 cases (5.3%). One patient required local revision due to CSF fistula (2.6%); another patient had to undergo secondary surgery to connect the catheter to a valve/abdominal catheter due to CSF malabsorption. However, in the remaining 37 patients, shunt independence was maintained during a median follow-up period of 12 months (IQR 3-32 months). No surgery-related mortality was observed.
CONCLUSIONS
CONCLUSIONS
sTVIP led to a significant symptom control and was associated with low operative morbidity, along with a high rate of ventriculoperitoneal shunt independency during the follow-up period. Therefore, sTVIP constitutes a highly effective and minimally invasive treatment option for tumor-associated obstructive hydrocephalus, even in cases with a narrow prepontine interval.
Identifiants
pubmed: 37676505
doi: 10.1007/s00701-023-05768-3
pii: 10.1007/s00701-023-05768-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Abdala-Vargas NJ, Cifuentes-Lobelo HA, Ordonez-Rubiano E, Patino-Gomez JG, Villalonga JF, Lucifero AG, Campero A, Forlizzi V, Baldoncini M, Luzzi S (2022) Anatomic variations of the floor of the third ventricle: surgical implications for endoscopic third ventriculostomy. Surg Neurol Int 13:218. https://doi.org/10.25259/SNI_404_2022
doi: 10.25259/SNI_404_2022
pubmed: 35673649
pmcid: 9168335
Bergsneider M, Miller C, Vespa PM, Hu X (2008) Surgical management of adult hydrocephalus. Neurosurgery 62(Suppl 2):643–659. https://doi.org/10.1227/01.neu.0000316269.82467.f7 . (discussion 659-660)
doi: 10.1227/01.neu.0000316269.82467.f7
pubmed: 18596440
Castro BA, Imber BS, Chen R, McDermott MW, Aghi MK (2017) Ventriculoperitoneal shunting for glioblastoma: risk factors, indications, and efficacy. Neurosurgery 80(3):421–430. https://doi.org/10.1227/NEU.0000000000001263
doi: 10.1227/NEU.0000000000001263
pubmed: 27218235
pmcid: 6257011
Cinalli G, Sainte-Rose C, Chumas P, Zerah M, Brunelle F, Lot G, Pierre-Kahn A, Renier D (1999) Failure of third ventriculostomy in the treatment of aqueductal stenosis in children. Neurosurg Focus 6(4):E5. https://doi.org/10.3171/foc.1999.6.4.6
doi: 10.3171/foc.1999.6.4.6
pubmed: 16681357
da Costa Val Filho JA, da Silva Gusmão SN, Furtado LMF, de Macedo Machado Filho G, Maciel FLA (2021) The role of the Liliequist membrane in the third ventriculostomy. Neurosurg Rev 44(6):3375–3385. https://doi.org/10.1007/s10143-021-01508-2
doi: 10.1007/s10143-021-01508-2
pubmed: 33624133
Dalrymple SJ, Kelly PJ (1992) Computer-assisted stereotactic third ventriculostomy in the management of noncommunicating hydrocephalus. Stereotact Funct Neurosurg 59(1–4):105–110. https://doi.org/10.1159/000098925
doi: 10.1159/000098925
pubmed: 1295027
Ebel H, Rieger A, Spies EH, Boker DK (1995) Stereotactic cysto-ventricular shunting in diencephalic (arachnoid) cysts and failure in cystic craniopharyngeoma. Minim Invasive Neurosurg 38(1):41–47. https://doi.org/10.1055/s-2008-1053459
doi: 10.1055/s-2008-1053459
pubmed: 7627584
Feng H, Huang G, Liao X, Fu K, Tan H, Pu H, Cheng Y, Liu W, Zhao D (2004) Endoscopic third ventriculostomy in the management of obstructive hydrocephalus: an outcome analysis. J Neurosurg 100(4):626–633. https://doi.org/10.3171/jns.2004.100.4.0626
doi: 10.3171/jns.2004.100.4.0626
pubmed: 15070116
Fukami S, Nakajima N, Okada H, Akimoto J, Miki T, Fukuhara H, Shishido-Hara Y, Nagao T, Tsuda M, Kohno M (2018) Pathologic findings and clinical course of midline paraventricular gliomas diagnosed using a neuroendoscope. World Neurosurg 114:e366–e377. https://doi.org/10.1016/j.wneu.2018.02.185
doi: 10.1016/j.wneu.2018.02.185
pubmed: 29530692
Fukuhara T, Luciano MG, Kowalski RJ (2002) Clinical features of third ventriculostomy failures classified by fenestration patency. Surg Neurol 58(2):102–110. https://doi.org/10.1016/s0090-3019(02)00773-5
doi: 10.1016/s0090-3019(02)00773-5
pubmed: 12453645
Hayashi N, Endo S, Hamada H, Shibata T, Fukuda O, Takaku A (1999) Role of preoperative midsagittal magnetic resonance imaging in endoscopic third ventriculostomy. Minim Invasive Neurosurg 42(2):79–82. https://doi.org/10.1055/s-2008-1053375
doi: 10.1055/s-2008-1053375
pubmed: 10422702
Javadpour M, Mallucci C, Brodbelt A, Golash A, May P (2001) The impact of endoscopic third ventriculostomy on the management of newly diagnosed hydrocephalus in infants. Pediatr Neurosurg 35(3):131–135. https://doi.org/10.1159/000050406
doi: 10.1159/000050406
pubmed: 11641621
Jiang L, Gao G, Zhou Y (2018) Endoscopic third ventriculostomy and ventriculoperitoneal shunt for patients with noncommunicating hydrocephalus: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 97(42):e12139. https://doi.org/10.1097/MD.0000000000012139
doi: 10.1097/MD.0000000000012139
pubmed: 30334940
Katzendobler S, Do A, Weller J, Dorostkar MM, Albert NL, Forbrig R, Niyazi M, Egensperger R, Thon N, Tonn JC, Quach S (2022) Diagnostic yield and complication rate of stereotactic biopsies in precision medicine of gliomas. Front Neurol 13:822362. https://doi.org/10.3389/fneur.2022.822362
doi: 10.3389/fneur.2022.822362
pubmed: 35432168
pmcid: 9005817
Kelly PJ (1991) Stereotactic third ventriculostomy in patients with nontumoral adolescent/adult onset aqueductal stenosis and symptomatic hydrocephalus. J Neurosurg 75(6):865–873. https://doi.org/10.3171/jns.1991.75.6.0865
doi: 10.3171/jns.1991.75.6.0865
pubmed: 1941115
Kelly PJ, Goerss S, Kall BA, Kispert DB (1986) Computed tomography-based stereotactic third ventriculostomy: technical note. Neurosurgery 18(6):791–794. https://doi.org/10.1227/00006123-198606000-00021
doi: 10.1227/00006123-198606000-00021
pubmed: 3526170
Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ (2001) The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours–a prospective study. Acta Neurochir (Wien) 143(6):539–545. https://doi.org/10.1007/s007010170058 . (discussion 545-536)
doi: 10.1007/s007010170058
pubmed: 11534670
Kundur AR, Singh I, Bulmer AC (2015) Bilirubin, platelet activation and heart disease: a missing link to cardiovascular protection in Gilbert’s syndrome? Atherosclerosis 239(1):73–84. https://doi.org/10.1016/j.atherosclerosis.2014.12.042
doi: 10.1016/j.atherosclerosis.2014.12.042
pubmed: 25576848
Kunz M, Schulte-Altedorneburg G, Uhl E, Schmid-Elsaesser R, Scholler K, Zausinger S (2008) Three-dimensional constructive interference in steady-state magnetic resonance imaging in obstructive hydrocephalus: relevance for endoscopic third ventriculostomy and clinical results. J Neurosurg 109(5):931–938. https://doi.org/10.3171/JNS/2008/109/11/0931
doi: 10.3171/JNS/2008/109/11/0931
pubmed: 18976087
Lenski M, Biczok A, Tonn JC, Kreth FW (2019) Stereotactic internal shunt placement in congenital intracranial cysts. World Neurosurg 123:e670–e677. https://doi.org/10.1016/j.wneu.2018.11.250
doi: 10.1016/j.wneu.2018.11.250
pubmed: 30576829
Mansoor N, Solheim O, Fredriksli OA, Gulati S (2021) Revision and complication rates in adult shunt surgery: a single-institution study. Acta Neurochir (Wien) 163(2):447–454. https://doi.org/10.1007/s00701-020-04526-z
doi: 10.1007/s00701-020-04526-z
pubmed: 33130985
McLaughlin MR, Wahlig JB, Kaufmann AM, Albright AL (1997) Traumatic basilar aneurysm after endoscopic third ventriculostomy: case report. Neurosurgery 41(6):1400–1403. https://doi.org/10.1097/00006123-199712000-00034 . (discussion 1403-1404)
doi: 10.1097/00006123-199712000-00034
pubmed: 9402593
Merkler AE, Ch’ang J, Parker WE, Murthy SB, Kamel H (2017) The rate of complications after ventriculoperitoneal shunt surgery. World Neurosurg 98:654–658. https://doi.org/10.1016/j.wneu.2016.10.136
doi: 10.1016/j.wneu.2016.10.136
pubmed: 27826086
Mohanty A, Biswas A, Satish S, Vollmer DG (2008) Efficacy of endoscopic third ventriculostomy in fourth ventricular outlet obstruction. Neurosurgery 63(5):905–913. https://doi.org/10.1227/01.NEU.0000333262.38548.E1 . (discussion 913-904)
doi: 10.1227/01.NEU.0000333262.38548.E1
pubmed: 19005381
Morota N, Watabe T, Inukai T, Hongo K, Nakagawa H (2000) Anatomical variants in the floor of the third ventricle; implications for endoscopic third ventriculostomy. J Neurol Neurosurg Psychiatry 69(4):531–534. https://doi.org/10.1136/jnnp.69.4.531
doi: 10.1136/jnnp.69.4.531
pubmed: 10990519
pmcid: 1737124
Rachinger W, Oehlschlaegel F, Kunz M, Fuetsch M, Schichor C, Thurau S, Schopohl J, Seelos K, Tonn JC, Kreth FW (2017) Cystic craniopharyngiomas: microsurgical or stereotactic treatment? Neurosurgery 80(5):733–743. https://doi.org/10.1227/NEU.0000000000001408
doi: 10.1227/NEU.0000000000001408
pubmed: 27973392
Reddy GK, Bollam P, Shi R, Guthikonda B, Nanda A (2011) Management of adult hydrocephalus with ventriculoperitoneal shunts: long-term single-institution experience. Neurosurgery 69(4):774–780. https://doi.org/10.1227/NEU.0b013e31821ffa9e . (discussion 780-771)
doi: 10.1227/NEU.0b013e31821ffa9e
pubmed: 21508873
Rohde V, Behm T, Ludwig H, Wachter D (2012) The role of neuronavigation in intracranial endoscopic procedures. Neurosurg Rev 35(3):351–358. https://doi.org/10.1007/s10143-011-0369-7
doi: 10.1007/s10143-011-0369-7
pubmed: 22170178
Rohde V, Gilsbach JM (2000) Anomalies and variants of the endoscopic anatomy for third ventriculostomy. Minim Invasive Neurosurg 43(3):111–117. https://doi.org/10.1055/s-2000-8330
doi: 10.1055/s-2000-8330
pubmed: 11108108
Sacko O, Boetto S, Lauwers-Cances V, Dupuy M, Roux FE (2010) Endoscopic third ventriculostomy: outcome analysis in 368 procedures. J Neurosurg Pediatr 5(1):68–74. https://doi.org/10.3171/2009.8.PEDS08108
doi: 10.3171/2009.8.PEDS08108
pubmed: 20043738
Schnell O, Scholler K, Ruge M, Siefert A, Tonn JC, Kreth FW (2008) Surgical resection plus stereotactic 125I brachytherapy in adult patients with eloquently located supratentorial WHO grade II glioma - feasibility and outcome of a combined local treatment concept. J Neurol 255(10):1495–1502. https://doi.org/10.1007/s00415-008-0948-x
doi: 10.1007/s00415-008-0948-x
pubmed: 18677635
Schulte-Altedorneburg G, Linn J, Kunz M, Bruckmann H, Zausinger S, Morhard D (2016) Visualization of Liliequist’s membrane prior to endoscopic third ventriculostomy. Radiol Med 121(3):200–205. https://doi.org/10.1007/s11547-015-0588-z
doi: 10.1007/s11547-015-0588-z
pubmed: 26474584
Schwartz C, Romagna A, Thon N, Niyazi M, Watson J, Belka C, Tonn JC, Kreth FW, Nachbichler SB (2015) Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas. Acta Neurochir (Wien) 157(10):1757–1764. https://doi.org/10.1007/s00701-015-2550-1 . (discussion 1764)
doi: 10.1007/s00701-015-2550-1
pubmed: 26298594
Souweidane MM, Morgenstern PF, Kang S, Tsiouris AJ, Roth J (2010) Endoscopic third ventriculostomy in patients with a diminished prepontine interval. J Neurosurg Pediatr 5(3):250–254. https://doi.org/10.3171/2009.10.PEDS09187
doi: 10.3171/2009.10.PEDS09187
pubmed: 20192641
Stoecklein VM, Kellert L, Patzig M, Kupper C, Giese A, Ruf V, Weller J, Kreth FW, Schoberl F (2021) Extended stereotactic brain biopsy in suspected primary central nervous system angiitis: good diagnostic accuracy and high safety. J Neurol 268(1):367–376. https://doi.org/10.1007/s00415-020-10157-2
doi: 10.1007/s00415-020-10157-2
pubmed: 32813052
Wu Y, Green NL, Wrensch MR, Zhao S, Gupta N (2007) Ventriculoperitoneal shunt complications in California: 1990 to 2000. Neurosurgery 61(3):557–562. https://doi.org/10.1227/01.NEU.0000290903.07943.AF . (discussion 562-553)
doi: 10.1227/01.NEU.0000290903.07943.AF
pubmed: 17881969